Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Aug;45(4):999-1006.
doi: 10.1007/s11096-023-01612-x. Epub 2023 Jun 17.

Development and validation of a Medication Adherence Universal Questionnaire: the MAUQ

Affiliations

Development and validation of a Medication Adherence Universal Questionnaire: the MAUQ

Ana C Cabral et al. Int J Clin Pharm. 2023 Aug.

Erratum in

Abstract

Background: Different questionnaires assess self-reported medication adherence and others quantify aspects of patients attitudes towards medication, but not together in a single instrument. Gathering these two aspects in a single instrument could reduce patients survey burden.

Aim: The aim of this study was to develop the Medication Adherence Universal Questionnaire (MAUQ) using the Maastricht Utrecht Adherence in Hypertension short version (MUAH-16) factorial structure as the hypothesized model.

Method: A multistep process started with the modification of the MUAH-16 to obtain the MAUQ. Patients using at least one antihypertensive medicine were recruited. The two questionnaires, the MUAH-16 and MAUQ, were applied. A confirmatory factor analysis (CFA) was performed using the initial MUAH-16 s-order 4-factor model. An additional bifactor model with four uncorrelated factors and an overall score was tested. The comparative fit index (CFI), root mean square error of approximation (RMSEA) with confidence intervals (CIs), and standardized root mean squared residual (SRMR) were used to assess both models.

Results: A sample of 300 hypertensive patients completed the instruments. The CFA with the second-order 4-factor solution resulted in similar results for the MUAH-16 and MAUQ: CFIs of 0.934 and 0.930, RMSEAs of 0.043 [CI 0.030-0.056] and 0.045 [CI 0.031-0.057] and SRMRs of 0.060 and 0.061, respectively. The CFA with the bifactor model showed slightly better results for both the MUAH-16 and MAUQ: CFIs of 0.974 and 0.976, RMSEAs of 0.030 [CI 0.005-0.046] and 0.028 [CI 0.001-0.044], and SRMRs of 0.043 and 0.044, respectively.

Conclusion: CFA demonstrated that the MAUQ presented a better fit to both models than the MUAH-16, obtaining a robust universal free instrument to assess medicine-taking behaviour and four medicine beliefs components.

Keywords: Medication adherence; Psychometrics; Questionnaires.

PubMed Disclaimer

Conflict of interest statement

The authors have no conflicts of interest to declare.

Figures

Fig. 1
Fig. 1
Bland-Altman analyses between Maastricht Utrecht Adherence in Hypertension short version (MUAH-16) and the Medication Adherence Universal Questionnaire (MAUQ®) overall and beliefs component scores. Note: Analysis for the ‘Lack of Discipline’ component was omitted because items were identical in both instruments
Fig. 2
Fig. 2
Confirmatory factor analysis of the Medication Adherence Universal Questionnaire (MAUQ®) using a second order 4-factor model (A) and using a bifactor model with the four factors uncorrelated (B)

References

    1. World Health Organization. Adherence to long-term therapies—evidence for action 2003. https://apps.who.int/iris/bitstream/handle/10665/42682/9241545992.pdf. Accessed 15 Dec 2022.
    1. Sawalha R, Hosseinzadeh H, Bajorek B. Culturally and linguistically diverse patients’ perspectives and experiences on medicines management in Australia: a systematic review. Int J Clin Pharm. 2023. 10.1007/s11096-023-01560-6. 10.1007/s11096-023-01560-6 - DOI - PubMed
    1. Allemann SS, van den Nieuwlaat R, et al. Matching adherence interventions to patient determinants using the theoretical domains Framework. Front Pharmacol. 2016;7:429. 10.3389/fphar.2016.00429. 10.3389/fphar.2016.00429 - DOI - PMC - PubMed
    1. Gregoriano C, Dieterle T, Breitenstein AL, et al. Does a tailored intervention to promote adherence in patients with chronic lung disease affect exacerbations? A randomized controlled trial. Respir Res. 2019;20(1):273. 10.1186/s12931-019-1219-3. 10.1186/s12931-019-1219-3 - DOI - PMC - PubMed
    1. Xu HY, Yu YJ, Zhang QH, et al. Tailored interventions to improve medication adherence for cardiovascular diseases. Front Pharmacol. 2020;11:510339. 10.3389/fphar.2020.510339. 10.3389/fphar.2020.510339 - DOI - PMC - PubMed

Substances

LinkOut - more resources